Home » VIOPTIX RECEIVES FDA CLEARANCE FOR ODISSEY TISSUE OXIMETER
VIOPTIX RECEIVES FDA CLEARANCE FOR ODISSEY TISSUE OXIMETER
ViOptix, a Fremont, Calif.-based developer and manufacturer of noninvasive local tissue oxygen measuring devices, has announced that its product, the ODISsey Tissue Oximeter, has received market clearance from the FDA. Market introduction of the ODISsey will take place immediately.
Yahoo News (http://biz.yahoo.com/prnews/050113/sfth056_1.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct